Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization

概要

Therapeutic antibody development is often framed as comprising two discrete stages: initial discovery of novel binders followed by iterative optimization to refine these hits into therapeutic-grade molecules. Models and methods often reflect these stages, with generative structure models applied to discovery and probabilistic black-box optimization methods applied to refinement. Here we propose to unify these stages by smoothly transitioning a generative discovery model into iterative optimization, allowing the handoff between the structure-based prior and supervision from wet lab data to be guided by the posterior uncertainty of a probabilistic surrogate. We show that this yields improvements in optimization efficiency in the low-N regime, as well as improved diversity amongst the optimized molecules.

参考リンク

• Paper ↗

リンク先のライセンス・再現性・データ条件をご確認ください。自動分類や実装の目安は保証ではありません。

実装を始めるプロンプト

参考リンクを確認したうえで、次の内容をコピーして利用できます。

# 論文・記事
Probabilistic Steering of Generative Priors for Lab-in-the-Loop Antibody Optimization

# 概要
Therapeutic antibody development is often framed as comprising two discrete stages: initial discovery of novel binders followed by iterative optimization to refine these hits into therapeutic-grade…

# 原典
https://arxiv.org/abs/2611.03844

上記の手法を実装してください。実行前に依存関係とライセンスを確認してください。